Hadi Hassannia | Immunology | Best Researcher Award

Posted on by ScienceFather

Dr. Hadi Hassannia | Immunology | Best Researcher Award

Dr. Hadi Hassannia, Mazandaran University of Medical Sciences, Iran

Dr. Hadi Hassannia is a prominent researcher at the Amol Faculty of Paramedical Sciences and the Immunogenetic Research Center of Mazandaran University of Medical Sciences in Sari, Iran. His research focuses on cancer immunotherapy and vaccine development, with significant publications on tumor inhibition and insulin-producing cells from stem cells. Dr. Hassannia possesses advanced technical skills in genetic engineering, antibody production, and molecular techniques. His experience as a lab technician in diagnostic laboratories has enriched his practical knowledge in various fields, including hematology and immunology. He is committed to advancing cancer research and therapeutic approaches. 🧬🔬💉

 

Publication Profile

Google Scholar

Work Experience

Dr. Hassannia has a robust work history, having served as a lab technician in various diagnostic laboratories in governmental hospitals from 2009 to 2017. His practical experience in clinical settings enriches his research with a real-world perspective, further bridging the gap between laboratory findings and clinical applications.

Technical Skills

Dr. Hassannia possesses a diverse skill set that enhances his research capabilities:

Genetic Engineering: He has significant experience in genetic engineering, including protein manipulation and monoclonal antibody production.

Immunological Techniques: Proficient in advanced immunological techniques such as flow cytometry, Western blotting, and ELISA, he is well-equipped to conduct comprehensive immunological research.

Molecular Techniques: His expertise extends to molecular biology techniques like PCR and gene transfection, which are essential for cancer research and therapeutic development.

Laboratory Animal Handling: His experience with laboratory animals allows him to perform complex experiments, including tumor induction, vital for his research in cancer models.

 

Research Interests

Cancer Vaccine Development: His work in developing cancer vaccines contributes to the growing field of immunotherapy, which seeks to harness the body’s immune system to combat cancer.

Immunotherapy: He is engaged in research focused on immunotherapy approaches for cancer treatment, highlighting his commitment to improving patient outcomes.

Cancer-Related Inflammation: Understanding the role of inflammation in cancer progression is a critical area of his research, as it can lead to new therapeutic targets.

Tumor Metastasis: His interest in tumor metastasis is vital for understanding how cancer spreads and devising strategies to prevent it.

Conclusion

Dr. Hadi Hassannia’s extensive research experience, impressive publication record, and technical skills make him an exceptional candidate for the Best Researcher Award. His contributions to cancer research, particularly in immunotherapy and vaccine development, demonstrate his potential to impact the field significantly and advance medical science.

 

Publication Top Notes

  • CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice – Cited by: 165, Year: 2017 🧬
  • Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles – Cited by: 85, Year: 2016 📉
  • Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccine – Cited by: 76, Year: 2020 💉
  • Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway – Cited by: 72, Year: 2019 🚀
  • Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine – Cited by: 67, Year: 2020 ⚔️
  • Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice – Cited by: 67, Year: 2018 🌱
  • Anti‐inflammatory and anti‐tumor effects of α-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model – Cited by: 59, Year: 2018 🌼
  • Myeloid-derived suppressor cells in B cell malignancies – Cited by: 59, Year: 2015 🦠
  • FOXP3 and TGF-β gene polymorphisms in allergic rhinitis – Cited by: 54, Year: 2011 🌿
  • Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet‐rich plasma composite nanofibers – Cited by: 53, Year: 2020 🧪

 

Azam Roohi | Nutrition and Immunology Award | Best Researcher Award

Posted on by ScienceFather

Dr. Azam Roohi | Nutrition and Immunology Award | Best Researcher Award

Dr. Azam Roohi, Tehran University of Medical Sciences, Iran

Dr. Azam Roohi is an esteemed immunologist at Tehran University of Medical Sciences. With a Ph.D. in Molecular Medicine and a career spanning over two decades, Dr. Roohi’s research focuses on immune system regulation, particularly through mTOR signaling and cytokine assays. She has authored numerous publications and taught advanced immunology courses. Dr. Roohi’s expertise includes monoclonal antibody production and flow cytometry. Her work has significant implications for diabetes and autoimmune diseases. 🌿🔬📚 She is known for her dedication to scientific advancement and education in the field of immunology. 📖👩‍🔬🌍

Publication profile

Orcid

Education

Dr. Azam Roohi holds a Ph.D. in Molecular Medicine from Tehran University of Medical Sciences, focusing on the impact of high glucose levels and oxidative stress on TGF beta secretion through the m-TOR signaling pathway in placental mesenchymal stem cells. With an academic journey spanning from Microbiology to Virology and finally Molecular Medicine, Dr. Roohi has amassed extensive expertise in molecular techniques such as PCR, qPCR, and protein analysis methods including SDS-PAGE and Western blotting.

Professional Experience 💼

Dr. Roohi’s career is characterized by significant contributions in research and academia. Notable roles include work at Tehran University of Medical Sciences’ Endocrinology and Metabolism Research Institute and the School of Public Health’s Department of Immunology. Her research spans from cytokine assays to monoclonal antibody production, with a focus on immune system regulation and immunometabolism.

Teaching

Dr. Roohi is committed to education, teaching advanced topics in immunology at Tehran University of Medical Sciences. Her instructional roles include courses on mTOR signaling and immune system regulation, highlighting her role in shaping the next generation of immunologists. Dr. Roohi’s dedication to both research and education underscores her multidimensional impact in the field of medical sciences.

Research Focus

Azam Roohi’s research primarily focuses on immunology and molecular biology, with a specific interest in autoimmune diseases, cancer immunotherapy, and vaccine development. Her work spans various aspects of immune system modulation, including the role of gamma delta T cells in cancer, therapeutic strategies involving cytokines like interferons, and the impact of metabolic conditions on cellular responses. Roohi’s contributions are characterized by a multidisciplinary approach that integrates cellular biology with clinical implications, aiming to elucidate novel targets for disease intervention and treatment. Her research not only explores fundamental immunological mechanisms but also explores practical applications in clinical settings, fostering advancements in therapeutic strategies. 🧬

 

Publication Top Notes

Vitamin D supplementation and calcium: Many-faced gods or nobody in fighting against Corona Virus Disease 2019

Controversial role of gamma delta T cells in pancreatic cancer

May interferon. be a novel therapeutic approach against COVID-19?

High Glucose Affects the Cytotoxic Potential of Rapamycin, Metformin and Hydrogen Peroxide in Cultured Human Mesenchymal Stem Cells

Healthy Adult LDL-C Bears Reverse Association with Serum IL-17A Levels

ABCA1 genetic polymorphisms and type 2 diabetes mellitus and its complications

Effect of metformin and celecoxib on cytotoxicity and release of GDF-15 from human mesenchymal stem cells in high glucose condition

Recent advances in targeting mTOR signaling pathway using small molecule inhibitors

Analysis of Knowledge, Attitudes, and Prevalence of Hepatitis B and C Seromarkers Among Barbers in Tehran

Serum IL-17, IL-23, and TGF-beta Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls

 

Hugues Piloquet | Immunology Award | Excellence in Academia Award

Posted on by ScienceFather

Dr. Hugues Piloquet | Immunology Award | Excellence in Academia Award

Dr. Hugues Piloquet, CHU de Nantes, University of Nantes, France

Dr. Hugues Piloquet is a distinguished pediatric gastroenterologist 🩺 with a career spanning over two decades. Graduating from the University of Nantes in 1989, he pursued specialized training in pediatric gastroenterology, hepatology, and nutrition. Dr. Piloquet has served in various prestigious roles, including as an Assistant at Necker Enfants Malades and later as a Practitioner at CHU de Nantes. His research contributions extend to INRA-France, where he was affiliated with the Physiology of Nutritional Adaptations unit. With expertise in pediatric gastrointestinal health, Dr. Piloquet continues to impact both clinical practice and research in his field.

 

Publication profile

Scopus

Education

Dr. Hugues Piloquet, born on July 18, 1965, embarked on his medical career with a Doctorate in Medicine from the University of Nantes in 1989. Specializing further, he obtained his DES in Pediatrics from the same institution in 1995, followed by a Master’s in Human Biology in 1993. His passion for pediatric gastroenterology led him to pursue advanced studies, including a DEA in Physiology and Pathophysiology of Human Nutrition from Paris VII. With a commitment to excellence, Dr. Piloquet completed a DIU in Pediatric Gastroenterology, Hepatology, and Nutrition in 1998.

Professional Experience 👨‍⚕️

Dr. Piloquet’s professional journey includes pivotal roles at esteemed institutions. He served as an Assistant at the Pediatric Gastroenterology Department under Pr. Claude Ricour at Necker Enfants Malades from 1995 to 1996. Progressing in his career, he assumed the role of Assistant-Chef de Clinique at the General Pediatrics Department under Pr. Alain Mouzard at CHU de Nantes in 1998. His dedication led him to become a Practitioner at CHU de Nantes in 1999, where he served as a hospital physician.

Research Focus

Dr. Hélène Piloquet’s research primarily focuses on pediatric nutrition and gastrointestinal health 🍼. She has contributed significantly to understanding the impact of early life gut microbiota on infant health, as evidenced by her work on synbiotic formulas and partially hydrolyzed whey-based follow-on formulas. Additionally, her studies explore the association between food fussiness in young children and family environmental factors. Through her research, Dr. Piloquet aims to optimize nutritional interventions for infants and toddlers, promoting healthy growth and development. Her interdisciplinary approach underscores the importance of nutrition in pediatric healthcare, addressing both clinical and environmental influences on children’s well-being.

Publication Top Notes

Food fussiness is associated with family environmental factors in 1-3-year-old children: A large-scale cross-sectional study

Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk

Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants

A new partially hydrolyzed whey-based follow-on formula with age-adapted protein content supports healthy growth during the first year of life

Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis

Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents

Frequency of Abnormal Glucose Tolerance Test Suggestive of Dumping Syndrome Following Oesophageal Atresia Repair

A 1-year survey of catheter-related infections in a pediatric university hospital: A prospective study

 

Peng Xiao | Macrophage Biology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Peng Xiao | Macrophage Biology | Best Researcher Award

Assoc Prof Dr. Peng Xiao, Zhejiang University, China

Dr. Peng Xiao, Assoc. Prof., is a distinguished immunologist specializing in Macrophage Biology. Holding an MD from Zhejiang University, he completed postdoctoral research at Harvard University before joining Zhejiang University as Assistant Professor, later promoted to Associate Professor. Dr. Xiao is a member of prestigious organizations including The American Association of Immunologists, Society for Mucosal Immunology, and Chinese Society for Immunology. He serves on the Editorial Board of the Journal of Leukocyte Biology. Passionate about unraveling mysteries of the immune system 🦠, Dr. Xiao’s research significantly contributes to understanding macrophage function and immunological processes.

Publication Profile:

Scopus

Orcid

Education:

Dr. Peng Xiao’s academic journey reflects a commitment to advancing knowledge in immunology. Beginning with his MD from Zhejiang University’s Institute of Immunology from 2011 to 2015 🎓, he laid a solid foundation in medical science. Eager to delve deeper into research, he pursued a postdoctoral position at Harvard University’s Medicine School from 2019 to 2021 🏥. During this time, he honed his expertise in macrophage biology, a field he’s passionate about.Returning to Zhejiang University in 2015, Dr. Xiao transitioned to the role of Assistant Professor, where he actively contributed to both teaching and research. Recognized for his exceptional dedication and contributions to the field, he was promoted to Associate Professor in 2019, reaffirming his position as a respected figure in academia 📚.

Employment:

Dr. Peng Xiao’s professional journey spans across two renowned institutions, showcasing his dedication to advancing research in immunology. At Zhejiang University in Hangzhou, China 🏫, Dr. Xiao has been deeply engaged in academia, contributing significantly as an Associate Professor. His tenure at this esteemed university underscores his commitment to education and research, where he actively participates in shaping the next generation of scholars and delving into the complexities of immunological science.In parallel, Dr. Xiao’s pursuit of excellence led him to Harvard Medical School in Boston, Massachusetts 🇺🇸, where he undertook a prestigious postdoctoral position. Immersed in the vibrant academic environment of one of the world’s leading medical institutions, Dr. Xiao furthered his expertise in immunology, particularly in the field of macrophage biology. His time at Harvard Medical School not only enriched his knowledge but also facilitated collaborations and networking opportunities with leading experts in the field.Through his employment at both Zhejiang University and Harvard Medical School, Dr. Xiao demonstrates his unwavering dedication to advancing scientific knowledge and making meaningful contributions to the field of immunology. His experiences at these distinguished institutions have undoubtedly shaped his trajectory as a respected researcher and educator.

Research Focus:

Dr. Peng Xiao’s research focuses on immunological mechanisms and their implications in various diseases, particularly emphasizing macrophage biology. His work spans understanding the role of macrophages in gut homeostasis, melanoma progression, and pulmonary fibrosis, among other conditions. Through his investigations, Dr. Xiao has elucidated pathways involving cytokines like TNF-α and IL-10, shedding light on potential therapeutic targets for inflammatory disorders and cancer. With a keen interest in unraveling the complexities of the immune system 🧬, his contributions pave the way for novel interventions and treatments to alleviate disease burden and improve patient outcomes.

Publication Top Notes:

  1. Mannose metabolism normalizes gut homeostasis by blocking the TNF-α-mediated proinflammatory circuit – Published in 2022 📚
  2. PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression – Published in 2022 🩺
  3. Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine – Published in 2022 🦠
  4. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production – Published in 2022 🫁
  5. Induction of co-inhibitory molecule CTLA-4 by human papillomavirus E7 protein through downregulation of histone methyltransferase JHDM1B expression – Published in 2019 🦠
  6. Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10 – Published in 2019 🧫
  7. USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance – Published in 2019 🔬
  8. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment – Published in 2018 🦠
  9. Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation – Published in 2017 🧬
  10. E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses – Published in 2017 🦠